Anatase TiO2 nanosheet films were fabricated on Mg–Zn alloy substrates through a special solvothermal method, aiming to improve the corrosion resistance of degradable Mg–Zn alloy stents. In this novel synthesis process, absolute alcohol was used as solvent, and small amounts of hydrofluoric acid and NH4F aqueous solution were used to adjust the hydrolysis rate of titanium precursors and the crystal morphology of anatase TiO2, respectively. The NH4F played a key role in the growth of TiO2 nanosheets by supplying fluorine ions (F−). The anatase TiO2 films had a compact surface consisting of interleaving nanosheets with thickness of about 50 nm. In simulated body fluids, the corrosion current density (Icorr) of Mg–Zn alloy substrates decreased from 789.5 to 24.4 µA cm−2, after being coated with the TiO2 nanosheet films.
SternbergK., GratzM., KoeckK., MostertzJ., BegunkR. and LoeblerM.: ‘Magnesium used in bioabsorbable stents controls smooth muscle cell proliferation and stimulates endothelial cells in vitro’, J. Biomed. Mater. Res. B Appl. Biomater., 2012,
100B, (1), 41–50. doi: 10.1002/jbm.b.31918
2.
LiuH., LengY. X., WanG. and HuangN.: ‘Corrosion susceptibility investigation of Ti–O film modified cobalt–chromium alloy (L-605) vascular stents by cyclic potentiodynamic polarization measurement’, Surf. Coat. Technol., 2011,
206, (5), 893–896. doi: 10.1016/j.surfcoat.2011.04.048
3.
ChenS., GuanS. K., HouS. S., WangL. G., ZhuS. J., WangJ. and LiW.: ‘Characterization and corrosion properties of Ti–O/HA composite coatings on Mg–Zn alloy’, Surf. Interface Anal., 2011,
43, (13), 1575–1580. doi: 10.1002/sia.3752
4.
HouS. S., ZhangR. R., GuanS. K., RenC. X., GaoJ. H. and LuQ. B.: ‘In vitro corrosion behavior of Ti–O film deposited on fluoride-treated Mg–Zn–Y–Nd alloy’, Appl. Surf. Sci., 2012,
258, (8), 3571–3577. doi: 10.1016/j.apsusc.2011.11.116
5.
TańskiT., LabiszK., LukaszkowiczK., ŚliwaA. and GołombekK.: ‘Characterisation and properties of hybrid coatings deposited onto magnesium alloys’, Surf. Eng., 2014,
30, (12), 927–932. doi: 10.1179/1743294413Y.0000000194
6.
ShaoZ., KongB., ZhaoY. and CaiZ.: ‘Composite film of magnesium alloy chemical conversion microarc oxidation’, Surf. Eng., 2014,
30, (12), 893–899. doi: 10.1179/1743294414Y.0000000328
7.
DeyA., UmaraniR., ThotaH. K., BandyopadhyayP., RajendraA., SharmaA. K. and MukhopadhyayA. K.: ‘Corrosion and nanoindentation studies of MAO coatings’, Surf. Eng., 2014,
30, (12), 913–919. doi: 10.1179/1743294413Y.0000000244
8.
RazaviM., FathiM., SavabiO., RazaviS. M., HeidariF., ManshaeiM., VashaeeD. and TayebiL.: ‘In vivo study of nanostructured diopside (CaMgSi2O6) coating on magnesium alloy as biodegradable orthopedic implants’, Appl. Surf. Sci., 2014,
313, 60–66. doi: 10.1016/j.apsusc.2014.05.130
9.
WenC., GuanS., PengL., RenC., WangX. and HuZ.: ‘Characterization and degradation behavior of AZ31 alloy surface modified by bone-like hydroxyapatite for implant applications’, Appl. Surf. Sci., 2009,
255, (13–14), 6433–6438. doi: 10.1016/j.apsusc.2008.09.078
10.
ChenX. B., YangH. Y., AbbottT. B., EastonM. A. and BirbilisN.: ‘Corrosion protection of magnesium and its alloys by metal phosphate conversion coatings’, Surf. Eng., 2014,
30, (12), 871–879. doi: 10.1179/1743294413Y.0000000235
LiuB. and AydilE. S.: ‘Growth of oriented single-crystalline rutile TiO2 nanorods on transparent conducting substrates for dye-sensitized solar cells’, J. Am. Chem. Soc., 2009,
131, (11), 3985–3990. doi: 10.1021/ja8078972
13.
VariolaF., VetroneF., RichertL., JedrzejowskiP., YiJ. H., ZalzalS., ClairS., SarkissianA., PerepichkaD. F., WuestJ. D., RoseiF., NanciA.: ‘Improving biocompatibility of implantable metals by nanoscale modification of surfaces: an overview of strategies, fabrication methods, and challenges’, Small, 2009,
5, (9), 996–1006. doi: 10.1002/smll.200801186
14.
TsyganovI., MaitzM. F. and WieserE.: ‘Blood compatibility of titanium-based coatings prepared by metal plasma immersion ion implantation and deposition’, Appl. Surf. Sci., 2004,
235, (1–2), 156–163. doi: 10.1016/j.apsusc.2004.05.134
15.
VirmaniR., GuagliumiG., FarbA., MusumeciG., GriecoN. and MottaT.: ‘Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?’, Circulation, 2004,
109, (6), 701–705. doi: 10.1161/01.CIR.0000116202.41966.D4
16.
van der GiessenW. J., SoropO., SerruysP. W., Peters-KrabbendamI. and van BeusekomH. M.: ‘Lowering the dose of sirolimus, released from a nonpolymeric hydroxyapatite coated coronary stent, reduces signs of delayed healing’, JACC: Cardiovasc. Interv., 2009,
2, (4), 284–290.
17.
WesselyR., HausleiterJ., MichaelisC., JaschkeB., VogeserM., MilzS., BehnischB., SchratzenstallerT., Renke-GluszkoM., StöverM., WintermantelE., KastratiA. and SchömigA.: ‘Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating’, Arterioscler. Thromb. Vasc. Biol., 2005,
25, (4), 748–753. doi: 10.1161/01.ATV.0000157579.52566.ee
18.
KokuboT. and TakadamaH.: ‘How useful is SBF in predicting in vivo bone bioactivity?’, Biomaterials, 2006,
27, (15), 2907–2915. doi: 10.1016/j.biomaterials.2006.01.017
19.
ASTM G31-72(2004): ‘Standard practice for laboratory immersion corrosion testing of metals’; 2004, Philadelphia, PA, USA
, ASTM Standard.
20.
HanX. G., KuangQ., JinM. S., XieZ. X. and ZhengL. S.: ‘Synthesis of titania nanosheets with a high percentage of exposed (001) facets and related photocatalytic properties’, J. Am. Chem. Soc., 2009,
131, (9), 3152–3153. doi: 10.1021/ja8092373
21.
YangH. G., SunC. H., QiaoS. Z., ZouJ., LiuG. and SmithS. C.: ‘Anatase TiO2 single crystals with a large percentage of reactive facets’, Nature, 2008,
453, (7195), 638–641. doi: 10.1038/nature06964
22.
AdabiM. and AmadehA.: ‘Effect of electrodeposition conditions on properties of Ni–Al composite coatings’, Surf. Eng., 2015,
31, (9), 650–658. doi: 10.1179/1743294414Y.0000000449
